Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Insight Venture Partners on their investment by participation in a EUR 56 000 000 investment round in Tink AB.
Mandate

Vinge advises Insight Venture Partners on their investment by participation in a EUR 56 000 000 investment round in Tink AB.

February 11, 2019 M&A

Founded in Stockholm in 2012, Tink AB is a cloud-based platform that provides the infrastructure and value-adding data products that are enabling the future of financial services.

Tink’s products can be used to develop standalone services or be integrated into existing banking applications. 

Insight Venture Partners is a leading global venture capital and private equity firm investing in high-growth technology and software companies that are driving transformative change in their industries.

Vinge’s team consisted of Christina Kokko, Ulrich Ziche, Michaela Cronemyr, Isabelle Jengsell (M&A), Malin Haag, Stina Bengtsson (Financial Services), Sara Strandberg (Employment), Nicklas Thorgerzon (IT/GDPR), Arvid Axelryd (Commercial Agreements), Lisa Hörnqvist (IP) and Frida Ställborn (Real Property).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025